259 related articles for article (PubMed ID: 8659332)
1. [Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
Hermans BP; Lorge F; Wese FX; Opsomer RJ; Van Cangh PJ
Acta Urol Belg; 1996 Mar; 64(1):27-31. PubMed ID: 8659332
[No Abstract] [Full Text] [Related]
2. [Neoadjuvant hormonal therapy for prostate cancer].
Miyakita H
Nihon Rinsho; 2005 Feb; 63(2):309-13. PubMed ID: 15714984
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated?
Scolieri MJ; Altman A; Resnick MI
J Urol; 2000 Nov; 164(5):1465-72. PubMed ID: 11025684
[TBL] [Abstract][Full Text] [Related]
4. [Effect of complete androgen block before radical prostatectomy for cancer of the prostate].
Gómez Veiga F; Lorenzo Patiño MJ; Díaz Bermúdez J; Duarte Novo J; Alvarez Castelo L; Chantada Abal V; Sánchez Rodríguez J; González Martín M
Arch Esp Urol; 1997 May; 50(4):355-63. PubMed ID: 9313044
[TBL] [Abstract][Full Text] [Related]
5. Intermittent complete androgen blockade in PSA relapse after radical prostatectomy and incidental prostate cancer.
Kurek R; Renneberg H; Lübben G; Kienle E; Tunn UW
Eur Urol; 1999; 35 Suppl 1():27-31. PubMed ID: 10081700
[TBL] [Abstract][Full Text] [Related]
6. [Radical prostatectomy with broadened scope of indications - analysis of early experience].
Chakarov S; Bechev R; Lazarov Z; Fachikov Ts; Rangelov S
Khirurgiia (Sofiia); 1999; 55(3):47-8. PubMed ID: 11194670
[No Abstract] [Full Text] [Related]
7. Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancer.
Gleave ME; Goldenberg SL; Jones EC; Bruchovsky N; Kinahan J; Sullivan LD
Semin Urol Oncol; 1996 May; 14(2 Suppl 2):39-45; discussion 46-7. PubMed ID: 8725890
[TBL] [Abstract][Full Text] [Related]
8. PSA response to thalidomide in patients with advanced prostate cancer.
Leibowitz R; Tucker SJ
Oncology (Williston Park); 2002 Sep; 16(9):1146, 1148. PubMed ID: 12380944
[No Abstract] [Full Text] [Related]
9. Clinical outcome of maximum androgen blockade using flutamide as second-line hormonal therapy for hormone-refractory prostate cancer.
Miyake H; Hara I; Eto H
BJU Int; 2005 Oct; 96(6):791-5. PubMed ID: 16153202
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer.
Wirth MP; Weissbach L; Marx FJ; Heckl W; Jellinghaus W; Riedmiller H; Noack B; Hinke A; Froehner M
Eur Urol; 2004 Mar; 45(3):267-70; discussion 270. PubMed ID: 15036669
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
Boccon-Gibod L
Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
[No Abstract] [Full Text] [Related]
12. Neoadjuvant hormonal treatment before radical prostatectomy.
Watson RB; Soloway MS
Semin Urol Oncol; 1996 May; 14(2 Suppl 2):48-55; discussion 55-6. PubMed ID: 8725891
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy and adjuvant endocrine therapy for prostate cancer with or without preoperative androgen deprivation: Five-year results.
Homma Y; Akaza H; Okada K; Yokoyama M; Moriyama N; Usami M; Hirao Y; Tsushima T; Sakamoto A; Ohashi Y; Aso Y;
Int J Urol; 2004 May; 11(5):295-303. PubMed ID: 15147545
[TBL] [Abstract][Full Text] [Related]
14. Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study.
Siddiqui SA; Boorjian SA; Inman B; Bagniewski S; Bergstralh EJ; Blute ML
J Urol; 2008 May; 179(5):1830-7; discussion 1837. PubMed ID: 18353378
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant hormone therapy and radical radiotherapy for localized prostate cancer: poorer biochemical outcome using flutamide alone.
Wilson KS; Ludgate CM; Wilson AG; Alexander AS
Can J Urol; 2000 Oct; 7(5):1099-103. PubMed ID: 11114872
[TBL] [Abstract][Full Text] [Related]
16. [Surgical and medical treatment for localized prostate cancer].
Kawai K
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
[TBL] [Abstract][Full Text] [Related]
17. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
Scalliet P
Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
[No Abstract] [Full Text] [Related]
19. Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.
Wood DP; Beaman A; Banerjee M; Powell I; Pontes E; Cher ML
Clin Cancer Res; 1998 Sep; 4(9):2119-23. PubMed ID: 9748128
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary results of radical surgery and radiotherapy of locally advanced prostate cancer (basal PSA >50 ng/ml)].
Kaprin AD; Khmelevskiĭ EV; Fadeev AV
Vopr Onkol; 2007; 53(4):479-81. PubMed ID: 17969415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]